Stonepine Capital Management LLC 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 4:16 pm Purchase | 2024-01-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Stonepine Capital Management LLC | 267,673 9.990% | 267,673 (New Position) | Filing |